....................................................................... |
| |
....................................................................... |
Veterinary APIs & Injection |
....................................................................... |
|
....................................................................... |
....................................................................... |
|
|
Lanospharma Laboratories Co.,Ltd Located in Chongqing,400012,China, is a Chinese leading Active pharmaceutical ingredients,Veterinary,pharmaceutical intermediates and Fine Chemicals supplier. |
Lanospharma Laboratories Co.,Ltd strong products main including Ophthalmology products (Latanoprost,Bimatoprost, Demecarium Bromide, Travoprost), Oncology bulk drugs and intermediates( Fludarabine phosphate, Cytarabine,Decitabine, Streptozocin, Tamoxifen citrate and intermediates); Cardiovascular ( Pimobendan, Dronedarone hydrochloride, Benazepril Hydrochloride, Ketanserin etc); Antifungals( Caspofungin, Amphotericin B); Respiratory( Tiotropium Bromide, Carbocisteine)
|
....................................................................................................................................................
|
Search a product by Name or CAS no.
|
|
|
....................................................................................................................................................
|
Lanospharma Laboratories Co.,Ltd |
Address: |
B2-4-6,No.180,Yuzhou Road,Yuzhong District, Chongqing,China 400012 |
Email: |
|
Contact |
Peter Wen +86 134 4004 8448 |
| Skype |
lanospharma |
KEY EVENTS (COOPERATION) |
2008. 01 |
We have successfully become the supplier of Applichem |
2008. 10 |
We have established a good cooperation with GD Pharma |
2009. 03 |
We have established a good cooperation with Brookwoodpharma USA |
2010. 03 |
We have established a good cooperation with Bachem |
2010. 04 |
We have established a good cooperation with Formosalab |
2011. 01 |
We have established a good cooperation with one member of Sanofi-aventis |
|
